Probiotic-Butyrate Feed Composition for Enterocyte Uptake

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The uptake of butyric acid or its salts at the intestinal level is impaired by inflammatory conditions, particularly in animals fed with high-fat diets, leading to reduced enterocyte health and overall wellness.

Innovation Solution

Simultaneously administering a probiotic, specifically Enterococcus faecium strain NCIMB 10415, with butyric acid or its salts, such as sodium butyrate, to enhance enterocyte uptake and improve intestinal health.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If butyric acid or its salts are administered to animals, then intestinal tissue health should be improved, but uptake is impaired by inflammatory conditions and high-fat diets

Engineering Contradiction:
Improvebutyric acid uptake reliabilityVSAvoidinflammatory conditions
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The probiotic Enterococcus faecium SF68 acts as an intermediary that restores the intestinal environment, thereby enabling butyric acid uptake. The probiotic modifies the intestinal conditions by reducing inflammation and improving barrier function, which indirectly facilitates the uptake of butyric acid without directly interacting with it.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The probiotic is administered beforehand to prepare the intestinal environment for butyric acid uptake. By pre-treating the intestinal tissue with the probiotic, the inflammatory conditions are mitigated and the uptake mechanism is restored before butyric acid administration becomes effective.

Inventive Principle:
Principle #10Preliminary action

2Use of energy by moving object

If high-fat diet is fed to animals, then energy intake is increased, but intestinal tissue damage and inflammation occur

Engineering Contradiction:
Improveenergy intakeVSAvoidintestinal tissue damage
Core Design Contradiction:
Use of energy by moving objectVSObject-affected harmful factors

Solution Approach 1:

The probiotic converts the harmful effects of high-fat diet-induced inflammation into beneficial outcomes by restoring intestinal barrier function and reducing inflammatory markers. The same high-fat diet conditions that cause damage become the backdrop against which the probiotic demonstrates its restorative capabilities, ultimately enabling better nutrient utilization including butyric acid uptake.

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

3Reliability

If probiotic and butyric acid are both administered, then enterocyte health is improved, but feed formulation complexity increases

Engineering Contradiction:
Improveenterocyte healthVSAvoidfeed formulation
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The probiotic Enterococcus faecium SF68 and butyric acid are merged into a single feed supplement formulation. This combination product integrates two active ingredients that work synergistically - the probiotic prepares the intestinal environment while butyric acid provides direct nutritional support to enterocytes, achieving enhanced health outcomes through a unified feed additive solution.

Inventive Principle:
Principle #5Merging (Combining)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enhances enterocyte health, resulting in improved weight gain and physiological and behavioral parameters in pets and livestock, as demonstrated by experimental studies on mice and chickens.

Implementation Method 1

the animal needs to adsorb butyric acid or its salts through an uptake mechanism of this short chain fatty acid (SCFA) into the enterocytes

Methodology Applied
Scientific EffectUptake mechanism:

Implementation Method 2

the animal needs to adsorb butyric acid or its salts through an uptake mechanism of this short chain fatty acid (SCFA) into the enterocytes

Methodology Applied
Scientific EffectAdsorption: Adsorption

Data Source

PatentUS20250367244A1Combined use of a probiotic and butyric acid to increase the enterocyte's health and consequently the wellness of pets and livestock
Publication Date: 2025.12.04 CERBIOS PHARMA SA
  • US20250367244A1 patent drawing
  • US20250367244A1 patent drawing
  • US20250367244A1 patent drawing

AI summary

The use of a probiotic, particularly the Enterococcus faecium strain NCIMB 10415 which is named SF68® as probiotic active ingredient, in combination with butyric acid or a salt thereof to increase the enterocyte's health and consequently the wellness of pets and livestock is described.